Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
For health systems, these findings endorse the broader application of GLP-1 therapies to mitigate cardiovascular risk in everyday practice
Two zucchini
Moderator: Dr Catherine Duggan, CEO, FIP, The Netherlands Panellists: - Dr Teddie Potter, Clinical Professor, Director of the Center for Planetary Health and Environmental Justice, School of Nursing, University of Minnesota, USA - Dr Filip Maric, Associate Professor, UiT The Arctic University of Norway, Environmental Physiotherapy Association, Norway - Clarisse Delorme, Senior Policy Advisor, WMA, France - Edward Krisiunas, President, WNWN International, Inc., USA - Dr Steven Mulligan, Dentist/ Clinical Teacher/ Founding member of FDI WDF Sustainability Task Team, FDI, UK Watch video Digital event video 5 June 2025, 14:00 - 15:30 CEST Expanding the Scope of Pharmacy Practice - The Role of a Sports Pharmacist More Most African countries do not have the role of sports pharmacy in their countries
GLP-1 RAs have demonstrated favorable trends toward improving endocrine and metabolic outcomes, including reductions in ALT, AST, HbA1c, body weight, BMI, LFC, and IHA
THE COMPLETE ZERO SUGAR HYDRATION: Hydrate fast with an advanced blend of 6 key electrolytes and 15 essential vitamins and nutrientsbuilt to support clean living, performance, and recovery
Key Point: Which Medications Are GLP-1 Agonists
